REDWOOD CITY, Calif., July 21 (San Francisco News Online) — A report that a preventive scan found a brain tumor has renewed attention on full-body MRI. But for most healthy adults, the main takeaway from major medical groups has not changed: a whole-body scan is not recommended as routine screening.
The Food and Drug Administration says it knows of no scientific evidence showing that scanning people without symptoms provides more benefit than harm. The American College of Radiology said in an April 2023 statement that there is not enough evidence to recommend total-body screening for people who have no symptoms, no risk factors and no family history suggesting serious disease.
What is a full-body MRI?
A full-body MRI is a magnetic resonance imaging scan that tries to look across many parts of the body in one visit. Companies that sell the scans market them as a way to find cancer, heart disease and other problems early. Prenuvo, for example, says its scan can detect more than 500 conditions, including tumors at an early stage.
That promise is part of the appeal. People often want reassurance that nothing is being missed. But doctors say that reassurance is only helpful if the scan can also show that it improves health outcomes.
Why do doctors warn against routine use?
The biggest concern is that a scan can find things that look abnormal but are not actually dangerous. The American Cancer Society says full-body MRI can turn up “spots” or “shadows” that are really normal variations in the body. Those findings can lead to anxiety, more imaging, biopsies or other procedures.
In its explainer on the test, the ACS says the risk comes from those downstream effects. The society also says insurance companies rarely pay for whole-body MRI because it is not part of standard medical care.
UCSF radiology researcher Dr. Rebecca Smith-Bindman has been even more direct. Speaking to CBS San Francisco, she said there is “not a stitch of evidence” that the scan helps people live longer or better, and warned that there could be “tremendous numbers of false positives.”
That concern is not limited to one physician. In a JAMA editorial discussed by ABC News, Matthew Davenport of the University of Michigan and Dr. Scott Reeder wrote that no major medical group recommends whole-body MRI for the general population because the benefits remain unproven. Davenport said the harms can come from invasive testing, surgery or follow-up of findings whose importance is unclear.
Does MRI itself have radiation risk?
No. The American Cancer Society says MRI does not use ionizing radiation, unlike CT scans. That means one common imaging risk is not part of the MRI picture.
But the absence of radiation does not make the scan automatically useful. Doctors worry more about false alarms, unnecessary follow-up and overdiagnosis — finding something that would never have caused symptoms or death.
The Cleveland Clinic says overdiagnosis is a real concern and also notes that full-body MRI can miss problems, creating false reassurance if a serious condition is not seen.
What about people with symptoms or higher risk?
That is a different question. Major medical groups are not rejecting all MRI screening. Instead, they say screening should be targeted to the right patients.
The U.S. Preventive Services Task Force, for example, gives pancreatic cancer screening in asymptomatic adults who are not known to be at high risk a D rating, meaning harms outweigh benefits. The American College of Preventive Medicine says doctors should not use whole-body scans for early tumor detection in people without symptoms of illness.
For people with a known inherited cancer syndrome, strong family history or a symptom that needs investigation, doctors may order imaging for a specific reason. That is very different from booking a scan to check everything.
The practical question for everyday readers
A single story about a tumor found early does not answer the bigger question of whether full-body MRI should become part of preventive care. The FDA, ACR and other medical groups say the current evidence does not support that step for the average healthy adult.
For readers weighing an elective scan, the current medical debate comes down to this: a full-body MRI may find something early, but it may also find things that trigger stress, costs and procedures without improving health. For now, major medical organizations say that tradeoff does not justify routine screening for people without symptoms or specific risk factors.
